EQT Life Sciences leads Series A funding round for maternal health company Nua Surgical

PR Newswire2024-12-06

Irish maternal health company Nua Surgical secures €6.5M in Series A funding led by EQT Life Sciences SteriCISION is the first self-retaining retractor designed specifically for Caesarean section (C-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2489285999?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/x0GYg4GR45XabkBjCPrOFw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f5f5d3a2778879bdc6d35f0c507a9dfb","is_english":true,"pubTime":"2024-12-06 18:40","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2489285999","market":"us","top_or_hot":-1,"title":"EQT Life Sciences leads Series A funding round for maternal health company Nua Surgical","media":"PR Newswire","content":"<div>\n<p>Irish maternal health company Nua Surgical secures €6.5M in Series A funding led by EQT Life Sciences\nSteriCISION is the first self-retaining retractor designed specifically for Caesarean section (C-...</p>\n\n<a href=\"https://finance.yahoo.com/news/eqt-life-sciences-leads-series-104000060.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EQT Life Sciences leads Series A funding round for maternal health company Nua Surgical</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEQT Life Sciences leads Series A funding round for maternal health company Nua Surgical\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-06 18:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/eqt-life-sciences-leads-series-104000060.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Irish maternal health company Nua Surgical secures €6.5M in Series A funding led by EQT Life Sciences\nSteriCISION is the first self-retaining retractor designed specifically for Caesarean section (C-...</p>\n\n<a href=\"https://finance.yahoo.com/news/eqt-life-sciences-leads-series-104000060.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4563","symbol_name":"昨日强势股","start_time":0,"source_url":"https://finance.yahoo.com/news/eqt-life-sciences-leads-series-104000060.html","article_id":"2489285999","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/x0GYg4GR45XabkBjCPrOFw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f5f5d3a2778879bdc6d35f0c507a9dfb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/eqt-life-sciences-leads-series-104000060.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2489285999","pubTimestamp":1733481600,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Irish maternal health company Nua Surgical secures 6.5M in Series A funding led by EQT Life Sciences. SteriCISION is the first self-retaining retractor designed specifically for Caesarean section  surgeries. Proceeds will be used for regulatory approval and commercialization of the SteriCISION C-section retractor. STOCKHOLM, Dec. 6, 2024 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the EQT Health Economics strategy has invested in Nua Surgical, an Irish medical device company innovating in maternal health. The 6.5 million Series A financing was led by EQT Life Sciences. The round was also supported by new investors Kidron Capital and the Texas Medical Center  Venture Fund and existing investors including Enterprise Ireland and business veterans from Ireland and the US. The proceeds will be used to drive the regulatory clearance and early commercialization of the company product, the SteriCISION C-Section Retractor. This innovative device is specifically designed to add","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4563":"昨日强势股","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","BK4585":"ETF&股票定投概念","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4588":"碎股","EQBBF":"EQT AB","BK4213":"石油与天然气的勘探与生产","BK4135":"资产管理与托管银行","EQT":"EQT能源","BK4168":"多种金属与采矿","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","TMC":"The Metals Company"},"translate_title":"殷拓生命科学领投孕产妇健康公司Nua Surgical A轮融资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EQT":1,"TMC":1,"EQBBF":0.9},"content_text":"Irish maternal health company Nua Surgical secures €6.5M in Series A funding led by EQT Life Sciences\nSteriCISION is the first self-retaining retractor designed specifically for Caesarean section (C-section) surgeries\nProceeds will be used for regulatory approval and commercialization of the SteriCISION C-section retractor\n\nSTOCKHOLM, Dec. 6, 2024 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the EQT Health Economics strategy has invested in Nua Surgical, an Irish medical device company innovating in maternal health. The €6.5 million Series A financing was led by EQT Life Sciences. The round was also supported by new investors Kidron Capital and the Texas Medical Center (TMC) Venture Fund and existing investors including Enterprise Ireland and business veterans from Ireland and the US. The proceeds will be used to drive the regulatory clearance and early commercialization of the company product, the SteriCISION C-Section Retractor. This innovative device is specifically designed to address the unique challenges of Caesarean-section (C-section) surgery.\nC-sections are the most common major surgical procedure globally, with over 30 million performed each year. The SteriCISION C-Section Retractor is the only self-retaining surgical retractor specifically designed for the unique dynamics of C-section surgery. This ergonomically designed and patented device provides fast, adjustable, and safe retraction, enabling clinicians to deliver the baby, repair tissue, and, crucially, identify bleeds. As a single-use sterile device, it aims to reduce the risk factors that lead to surgical complications, benefiting the patient, the clinician, and the healthcare system. The new investment will support Nua Surgical's next phase of development and the early commercialization of SteriCISION. This includes expanding the team, establishing manufacturing in Ireland, and meeting the regulatory requirements necessary to gain FDA clearance.\nBarry McCann, CEO of Nua Surgical, commented, \"Securing this Series A financing is a crucial milestone for Nua Surgical. It not only provides the capital needed to advance our product but also brings on board a group of experienced investors who share our vision for transforming maternal health. We are eager to leverage their expertise as we move towards commercializing SteriCISION.\"\n\"Nua Surgical's SteriCISION C-Section Retractor has the potential to significantly enhance outcomes for mothers undergoing C-section procedures,\" said Anne Portwich, Partner at EQT. \"We are excited to support the company's journey towards market entry. This innovative device has the potential to improve the quality of care and reduce healthcare costs, making it a perfect fit for our EQT Health Economics strategy.\"\nWith the closure of this round, Anne Portwich, Partner at EQT, and Anula Jayasuriya, Co-Founder of Kidron Capital, will join the Nua Surgical Board of Directors, while Gabrielle Guttman of TMC Venture Fund and Prashanthi Ramesh of EQT will serve as Board Observers.\nContactEQT Press Office, press@eqtpartners.com\nThis information was brought to you by Cision http://news.cision.com\nhttps://news.cision.com/eqt/r/eqt-life-sciences-leads-series-a-funding-round-for-maternal-health-company-nua-surgical,c4076882\nThe following files are available for download:\n\n\n\n\nhttps://mb.cision.com/Main/87/4076882/3156236.pdf \nPR_EQT_Nua Surgical_06.12.24 \n\n\nhttps://news.cision.com/eqt/i/shutterstock-1935893170-c-sction-small---licenced-by-nua-surgical,c3358653 \nshutterstock 1935893170 C-Sction small - Licenced by Nua Surgical \n\n\n\n\n View original content:https://www.prnewswire.co.uk/news-releases/eqt-life-sciences-leads-series-a-funding-round-for-maternal-health-company-nua-surgical-302324810.html","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2489285999"}